| The proteogenomic subtypes of acute myeloid leukemia AK Jayavelu, S Wolf, F Buettner, G Alexe, B Häupl, F Comoglio, ... Cancer Cell 40 (3), 301-317. e12, 2022 | 94 | 2022 |
| Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases S Weber, M Hogardt, C Reinheimer, TA Wichelhaus, VAJ Kempf, J Kessel, ... Annals of Hematology 98, 763-773, 2019 | 39 | 2019 |
| SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma AC Wilke, C Doebele, A Zindel, KS Lee, SA Rieke, M Ceribelli, ... Blood, The Journal of the American Society of Hematology 139 (4), 538-553, 2022 | 35 | 2022 |
| Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma JC Enßle, J Campe, A Schwenger, E Wiercinska, H Hellstern, R Dürrwald, ... Blood, The Journal of the American Society of Hematology 139 (1), 137-142, 2022 | 34 | 2022 |
| Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells S Roesler, I Eckhardt, S Wolf, S Fulda Oncotarget 7 (4), 3709, 2016 | 34 | 2016 |
| Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma JC Enssle, J Campe, S Büchel, A Moter, F See, K Grießbaum, MA Rieger, ... Cancer Cell 40 (6), 587-589, 2022 | 24 | 2022 |
| Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation S Scheich, JC Enßle, VT Mücke, F Acker, L Aspacher, S Wolf, AC Wilke, ... PloS one 14 (11), e0225035, 2019 | 15 | 2019 |
| Anti-EGFR reintroduction and rechallenge in metastatic colorectal cancer (mCRC): A real-world analysis MS Schulz, S Wolf, V Struck, N Thomas, G Husman, S Zeuzem, C Koch, ... Cancers 14 (7), 1641, 2022 | 11 | 2022 |
| Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation S Weber, S Scheich, A Magh, S Wolf, JC Enßle, U Brunnberg, ... International Journal of Infectious Diseases 99, 428-436, 2020 | 10 | 2020 |
| Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears J Kockwelp, S Thiele, J Bartsch, L Haalck, J Gromoll, S Schlatt, R Exeler, ... Blood advances 8 (1), 70-79, 2024 | 8 | 2024 |
| CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells T Bexte, N Albinger, A Al Ajami, P Wendel, L Buchinger, A Gessner, ... Nature Communications 15 (1), 8439, 2024 | 5 | 2024 |
| Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia E Felipe Fumero, C Walter, JM Frenz, F Seifert, V Alla, T Hennig, ... Blood 143 (22), 2284-2299, 2024 | 4 | 2024 |
| PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia I Alshamleh, N Kurrle, P Makowka, R Bhayadia, R Kumar, S Süsser, ... Leukemia 37 (12), 2367-2382, 2023 | 4 | 2023 |
| Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience JC Enßle, S Wolf, S Scheich, S Weber, M Kramer, L Ruhnke, ... British Journal of Cancer 129 (7), 1126-1133, 2023 | 4 | 2023 |
| CONIFER-Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload HR Bruch, Y Dencausse, J Heßling, G Michl, R Schlag, A Skorupa, ... Oncology Research and Treatment 39 (7-8), 424-431, 2016 | 4 | 2016 |
| Cytokine-responsive T-and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients JC Enssle, J Campe, A Moter, I Voit, A Gessner, W Yu, S Wolf, B Steffen, ... Leukemia 38 (1), 168-180, 2024 | 3 | 2024 |
| High CD34 positive stem cell dosage improves thrombocyte recovery in obese myeloma patients undergoing autologous stem cell transplantation JC Enßle, S Wolf, I von Metzler, S Weber, H Bialleck, E Seifried, H Serve, ... Leukemia & Lymphoma 62 (13), 3283-3287, 2021 | 2 | 2021 |
| SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism F Mayr, V Kruse, DC Fuhrmann, S Wolf, J Löber, S Alsouri, N Paglilla, ... Haematologica 109 (5), 1445, 2023 | 1 | 2023 |
| Impact of Body Mass Index on Patient Outcome in Acute Myeloid Leukemia Patients Receiving Intensive Induction Therapy: A Real-World Registry Experience JC Enssle, S Wolf, S Scheich, S Weber, M Kramer, L Ruhnke, ... Blood 138 (Supplement 1), 3370-3370, 2021 | 1 | 2021 |
| Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes JC Enssle, B Häupl, A Qoku, B Wang, GW Wright, S Barrans, MA Care, ... Blood 144, 229, 2024 | | 2024 |
